HOME >> BIOLOGY >> NEWS
Antiretroviral resistance testing in HIV infected patients improves health and saves costs

During HIV treatment resistance mutations of the virus to antiretroviral drugs may occur and the treatment regimen become less effective. In the present study the authors compared the cost-effectiveness of genotypic antiretroviral resistance testing versus expert opinion for treatment optimization in HIV infected patients with treatment failure. The study is based on data from the Swiss HIV Cohort Study (www.shcs.ch), which is one of the largest cohort studies on HIV disease including patients from all University Clinics and two state hospitals in Switzerland. In this study, both health care costs and productivity costs, i.e. costs due to absence from work because of ill-health, were included in the analysis. Using most recent scientific methods, the authors could show that antiretroviral resistance testing not only increases life expectancy and quality-of-life, but also results in cost savings to society.

"This is the first study that shows that resistance testing not only improves the health of the patients but is also beneficial to the society at large when job productivity changes are considered," said Pedram Sendi, first author and principal investigator, from the Clinic of Infectious Diseases & Hospital Epidemiology of the Basel University Hospital. "We are convinced that our study will be noticed in many countries as it also documents the clinical benefit of antiretroviral resistance testing," comment Manuel Battegay from the Basel University Hospital and Huldrych Gnthard from the Zurich University Hospital, co-principals of this cost-effectiveness study.

In times of increasing pressures to contain health care costs cost-effectiveness analyses are an important source of information to evaluate whether health interventions represent "value for money." This may help to prioritize resource allocation in health care by finding those health technologies that offer the most health outcomes for the resources
'"/>

Contact: Pedram Sendi
pedram.sendi@unibas.ch
41-078-691-8181
Public Library of Science
23-Jan-2007


Page: 1 2

Related biology news :

1. Support for chromosomal theory of cancer found in cancers development of drug resistance
2. 454 sequencing identifies HIV drug resistance at early stage
3. Ultra deep sequencing identifies HIV drug resistance at early stage
4. Cytokine resistance contributes to pathology of type 2 diabetes
5. Largest synthetic gene ever built offers insights into anti-malarial drug resistance
6. WHO data confirms low level of resistance to Tamiflu
7. Unstable leukemia stem cells may predispose patients to drug resistance
8. Gene profiling predicts resistance to breast cancer drug Herceptin
9. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
10. What recognizes what in plant disease resistance?
11. New HIV test may predict drug resistance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/17/2019)... ... July 18, 2019 , ... Flagship Biosciences, the advanced ... to its executive team as Vice President of Operations. Ms. James brings a ... new role, Ms. James is responsible for ensuring on-time delivery of all projects ...
(Date:7/17/2019)... ... July 17, 2019 , ... ... acclaimed pediatric urologists are among the professionals honored in U.S. News & ... among the country’s pediatric healthcare landscape. , Georgia Urology’s wholly-owned subsidiary, ...
(Date:7/17/2019)... ... 15, 2019 , ... RCH Solutions (RCH), a ... companies, announces the availability of new specialty advisory practice, a Public Cloud Managed ... emerging bio-pharma companies interested in achieving specific outcomes related to public Cloud adoption. ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Mytonomy, the leader ... leader in opioid treatment, announced today they are partnering to combat the opioid ... deployed its virtual care platform at the Mayo Clinic to drive shared decision ...
(Date:6/11/2019)... ... June 11, 2019 , ... A study released today in ... are able to incorporate into human CD34+ cells, modifying their gene expression and ... increased the cells’ ability to lodge into bone marrow. This research performed by ...
(Date:5/31/2019)... ... 29, 2019 , ... For many years, the primary forms of cancer treatment ... therapies. Advances in immuno-oncology have led to the advent of Chimeric Antigen Receptor T ... cell receptors known as “CARs”. The CAR enables the final product to produce chemicals ...
(Date:5/31/2019)... , ... May 30, 2019 , ... ... thinking on Data Integrity on July 08-09, 2019 in Boston, MA. This peer ... and medical device organizations. , The training will kick off with a compendial ...
Breaking Biology Technology:
Cached News: